February 1, 2004
There is debate as to whether physicians treating DKA can prevent or predict the occurrence of cerebral edema and the appropriate site(s) for children with DKA to be managed. There is an agreement that prevention of DKA and reduction of its incidence should be a goal in managing children with diabetes.
To explore these issues, the Lawson Wilkins Pediatric Endocrine Society (LWPES) and the European Society for Pediatric Endocrinology (ESPE) convened a panel of expert physicians to produce this consensus statement. This is directed at standardizing management of DKA with the goal of minimizing risk for cerebral edema.